France· FR:64450362
FETCROJA 1 g, poudre pour solution à diluer pour perfusion
A cefiderocol product containing tosilate de sulfate de céfidérocol, registered in France by SHIONOGI (PAYS BAS). The same ATC class is registered in 13 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Cefiderocol is registered in 13 of 19 countries.
Countries holding a registration under ATC J01DI04 (cefiderocol), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 8 of them publish a price we can compare per daily dose
Cefiderocol · ATC J01DI04
13 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- United Kingdom
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- TOSILATE DE SULFATE DE CÉFIDÉROCOL
- Manufacturer
- SHIONOGI (PAYS BAS)
- Country
- France (FR)
- ATC code
- J01DI04
- ATC class
- Cefiderocol
- Defined daily dose
- 6 g, P
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip13340095507549310 flacon(s) en verre de 14 ml
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
22 interactions on record for cefiderocol.
Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cefiderocol · interactions on record
22 records
- 5 severe
- 17 moderate
Most severe, free to view
- BupropionN06AX12severe
- BupropionN07BA02severe
- HydrocodoneR05DA03severe
- IohexolV08AB02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Cefiderocol in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsFetcroja 1 g, poeder voor concentraat voor oplossing voor infusieShionogi B.V.
- CzechiaFETCROJAShionogi B.V., Amsterdam
- SpainFETCROJA 1 G POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSIONShionogi B.V.
- FinlandFetcrojaShionogi B.V.
- United KingdomFetcroja 1g powder for concentrate for solution for infusion vialsShionogi BV
- IrelandFetcroja 1 g powder for concentrate for solution for infusionShionogi B.V.
- IcelandFetcrojaShionogi B.V.
- NorwayFetcrojaShionogi B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Fetcroja
- Liechtenstein · Fetcroja
- Norway · Fetcroja
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8a875078-6f49-49d2-a39f-76236189397a GET /v1/drugs/8a875078-6f49-49d2-a39f-76236189397a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "64450362",
"date_amm": "2020-04-23",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/20/1434",
"substance": "TOSILATE DE SULFATE DE CÉFIDÉROCOL",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "poudre pour solution à diluer pour perfusion",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about cefiderocol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.